Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lux

Showing results (101-110 of 233) with videos related to

Pageof 24
Sort By:
Breast Cancer Research and Treatment|December 1, 2007
Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patientsPeter Andreas Fasching, Christian R Loehberg, Pamela L Strissel, et al.
Onkologie|April 15, 2010
Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health systemMichael P Lux, Achim Wöckel, Agnes Benedict, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Full Field Digital Mammography (FFDM) versus CMOS Technology versus Tomosynthesis (DBT) - Which System Increases the Quality of Intraoperative Imaging?R Schulz-Wendtland, G Dilbat, M Bani, et al.
BMC Cancer|October 31, 2018
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancerPaul Gass, Michael P Lux, Claudia Rauh, et al.
Der Pathologe|November 9, 2018
[TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes]R Erber, A Hartmann, M W Beckmann, et al.
Geburtshilfe Und Frauenheilkunde|September 16, 2014
Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center StudyM P Lux, C S Sell, P A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Mammographic Density and Prediction of Nodal Status in Breast Cancer PatientsC C Hack, L Häberle, K Geisler, et al.
Biomed Research International|April 15, 2014
Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patientsAlexander Hein, Christian M Bayer, Michael G Schrauder, et al.
Breast Care (Basel, Switzerland)|July 12, 2021
Influence of Family History of Breast or Ovarian Cancer on Pathological Complete Response and Long-Term Prognosis in Breast Cancer Patients Treated with Neoadjuvant ChemotherapyMarius Wunderle, Lothar Häberle, Alexander Hein, et al.
Archives of Gynecology and Obstetrics|April 11, 2020
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer centerChristian R Loehberg, Julia Meyer, Lothar Häberle, et al.
Pageof 24

Showing results (101-110 of 233) with videos related to

Sort By:
Pageof 24
Breast Cancer Research and Treatment|December 1, 2007
Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patientsPeter Andreas Fasching, Christian R Loehberg, Pamela L Strissel, et al.
Onkologie|April 15, 2010
Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health systemMichael P Lux, Achim Wöckel, Agnes Benedict, et al.
Geburtshilfe Und Frauenheilkunde|December 8, 2015
Full Field Digital Mammography (FFDM) versus CMOS Technology versus Tomosynthesis (DBT) - Which System Increases the Quality of Intraoperative Imaging?R Schulz-Wendtland, G Dilbat, M Bani, et al.
BMC Cancer|October 31, 2018
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancerPaul Gass, Michael P Lux, Claudia Rauh, et al.
Der Pathologe|November 9, 2018
[TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes]R Erber, A Hartmann, M W Beckmann, et al.
Geburtshilfe Und Frauenheilkunde|September 16, 2014
Time and Resources Needed to Document Patients with Breast Cancer from Primary Diagnosis to Follow-up - Results of a Single-center StudyM P Lux, C S Sell, P A Fasching, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Mammographic Density and Prediction of Nodal Status in Breast Cancer PatientsC C Hack, L Häberle, K Geisler, et al.
Biomed Research International|April 15, 2014
Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patientsAlexander Hein, Christian M Bayer, Michael G Schrauder, et al.
Breast Care (Basel, Switzerland)|July 12, 2021
Influence of Family History of Breast or Ovarian Cancer on Pathological Complete Response and Long-Term Prognosis in Breast Cancer Patients Treated with Neoadjuvant ChemotherapyMarius Wunderle, Lothar Häberle, Alexander Hein, et al.
Archives of Gynecology and Obstetrics|April 11, 2020
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer centerChristian R Loehberg, Julia Meyer, Lothar Häberle, et al.
Pageof 24